Follow-up of 9 months showed no recurrence of hematuria by anti-tuberculous treatment.
经抗结核治疗9个月,随访至今无血尿复发。
Thus, patients with RCC who received vitespen after nephrectomy showed no increased recurrence-free survival.
因此,长期存活的肾切除术后接受噬菌体接种的肾细胞癌病人显示复发率并未增高。
Results: the tumor has been completely removed by laparoscopy for the carcinoma patient who showed improved symptoms after the surgery and no recurrence after half a year follow - up.
结果:本例肾上腺皮质癌患者经后腹腔镜将肿瘤完整切除,临床症状缓解,随访半年,无复发。
应用推荐